Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (31-40 of 210) with videos related to

Pageof 21
Sort By:
Chemical Science|June 17, 2026
Lipid nanoparticle formulations including stereochemically defined glycomacromolecules for delivery of saRNAJonas Becker, Beatriz Dias-Barbieri, Robin J Shattock, et al.
Protein Expression and Purification|March 31, 2018
A systematic analysis of the expression of the anti-HIV VRC01 antibody in Pichia pastoris through signal peptide optimizationRochelle Aw, Paul F McKay, Robin J Shattock, et al.
AIDS (London, England)|December 31, 2008
HIV-1 infection of human penile explant tissue and protection by candidate microbicidesLucia Fischetti, Sheila M Barry, Thomas J Hope, et al.
AIDS Research and Human Retroviruses|July 31, 2018
The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIVEster Lopez, Robin J Shattock, Stephen J Kent, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 28, 2009
Design, expression, and characterization of a multivalent, combination HIV microbicideAmy Sexton, Sarah Harman, Robin J Shattock, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2009
Reverse transcriptase inhibitors as potential colorectal microbicidesCarolina Herrera, Martin Cranage, Ian McGowan, et al.
AIDS (London, England)|August 4, 2011
Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explantsCarolina Herrera, Martin Cranage, Ian McGowan, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicideSarah Harman, Carolina Herrera, Naomi Armanasco, et al.
The Journal of Organic Chemistry|November 29, 2024
Advancements in Loop Cyclization Approaches for Enhanced Peptide Therapeutics for Targeting Protein-Protein InteractionsLucia Lombardi, Luke A Granger, Robin J Shattock, et al.
AMB Express|March 26, 2017
Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastorisRochelle Aw, Paul F McKay, Robin J Shattock, et al.
Pageof 21

Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
Chemical Science|June 17, 2026
Lipid nanoparticle formulations including stereochemically defined glycomacromolecules for delivery of saRNAJonas Becker, Beatriz Dias-Barbieri, Robin J Shattock, et al.
Protein Expression and Purification|March 31, 2018
A systematic analysis of the expression of the anti-HIV VRC01 antibody in Pichia pastoris through signal peptide optimizationRochelle Aw, Paul F McKay, Robin J Shattock, et al.
AIDS (London, England)|December 31, 2008
HIV-1 infection of human penile explant tissue and protection by candidate microbicidesLucia Fischetti, Sheila M Barry, Thomas J Hope, et al.
AIDS Research and Human Retroviruses|July 31, 2018
The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIVEster Lopez, Robin J Shattock, Stephen J Kent, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 28, 2009
Design, expression, and characterization of a multivalent, combination HIV microbicideAmy Sexton, Sarah Harman, Robin J Shattock, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2009
Reverse transcriptase inhibitors as potential colorectal microbicidesCarolina Herrera, Martin Cranage, Ian McGowan, et al.
AIDS (London, England)|August 4, 2011
Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explantsCarolina Herrera, Martin Cranage, Ian McGowan, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicideSarah Harman, Carolina Herrera, Naomi Armanasco, et al.
The Journal of Organic Chemistry|November 29, 2024
Advancements in Loop Cyclization Approaches for Enhanced Peptide Therapeutics for Targeting Protein-Protein InteractionsLucia Lombardi, Luke A Granger, Robin J Shattock, et al.
AMB Express|March 26, 2017
Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastorisRochelle Aw, Paul F McKay, Robin J Shattock, et al.
Pageof 21